https://www.wsj.com/health/pharma/bristol-myers-to-buy-karuna-therapeutics-for-14-billion-6a6c1bce
0
0
32 words
0
Comments
Cash deal would help Bristol establish a beachhead in neuroscience drugs, including a schizophrenia treatment up for approval
You are the first to view
Create an account or login to join the discussion